Yulu Qianxing is an artificial intelligence drug research and development platform. It uses artificial intelligence, quantum mechanics and molecular mechanics algorithms as its core technologies to empower new drug research and development through simulation operations. The company has established a world-leading artificial intelligence drug research and development platform by combining the new generation of molecular simulation AI core algorithms and artificial intelligence models of independent innovation. The whole process of drug development. Recently, Yulu Qianxing completed an angel round of financing. The investor is Hangzhou Shileng Investment Management Co., Ltd. This round of financing is mainly to introduce strategic shareholders and help the company’s business development.
This article is reproduced from: https://www.itjuzi.com/investevent/13372434
This site is for inclusion only, and the copyright belongs to the original author.